Mohammed Soutto1,2, Zheng Chen2, Ahmed M Katsha2, Judith Romero-Gallo3, Uma S Krishna3, M Blanca Piazuelo3, M Kay Washington4, Richard M Peek3,5, Abbes Belkhiri2, Wael M El-Rifai1,2,5. 1. Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, Tennessee. 2. Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee. 3. Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. 4. Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee. 5. Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee.
Abstract
BACKGROUND: Infection with Helicobacter pylori, a high-risk factor for gastric cancer, is frequently associated with chronic inflammation through activation of nuclear factor κB (NF-κB). Trefoil factor 1 (TFF1) is a constitutively expressed protein in the stomach that has tumor-suppressor functions and plays a critical role in maintaining mucosal integrity. This study investigated the role of TFF1 in regulating the proinflammatory response to H. pylori infections. METHODS: For in vitro studies, immunofluorescence, luciferase reporter assays, Western blots, and quantitative real-time polymerase chain reaction were performed to investigate the activation of NF-κB and its target genes in response to infections with H. pylori strains J166 and 7.13. In addition, Tff1-knockout (KO) and Tff1-wild-type mice were used for infections with the H. pylori strain called premouse Sydney strain 1. RESULTS: The reconstitution of TFF1 expression in gastric cancer cells significantly suppressed H. pylori-mediated increases in NF-κB-p65 nuclear staining, transcriptional activity, and expression of proinflammatory cytokine genes (tumor necrosis factor α, interleukin 1β, chemokine [C-X-C motif] ligand 5, and interleukin 4 receptor) that were associated with reductions in the expression and phosphorylation of NF-κB-p65 and IκB kinase α/β proteins. The in vivo studies using the Tff1-KO mouse model of gastric neoplasia confirmed the in vitro findings. Furthermore, they demonstrated increases in chronic inflammation scores and in the frequency of invasive gastric adenocarcinoma in the Tff1-KO mice infected with H. pylori versus the uninfected Tff1-KO mice. CONCLUSIONS: These findings underscore an important protective role of TFF1 in abrogating H. pylori-mediated inflammation, a crucial hallmark of gastric tumorigenesis. Therefore, loss of TFF1 expression could be an important step in H. pylori-mediated gastric carcinogenesis.
BACKGROUND:Infection with Helicobacter pylori, a high-risk factor for gastric cancer, is frequently associated with chronic inflammation through activation of nuclear factor κB (NF-κB). Trefoil factor 1 (TFF1) is a constitutively expressed protein in the stomach that has tumor-suppressor functions and plays a critical role in maintaining mucosal integrity. This study investigated the role of TFF1 in regulating the proinflammatory response to H. pylori infections. METHODS: For in vitro studies, immunofluorescence, luciferase reporter assays, Western blots, and quantitative real-time polymerase chain reaction were performed to investigate the activation of NF-κB and its target genes in response to infections with H. pylori strains J166 and 7.13. In addition, Tff1-knockout (KO) and Tff1-wild-type mice were used for infections with the H. pylori strain called premouse Sydney strain 1. RESULTS: The reconstitution of TFF1 expression in gastric cancer cells significantly suppressed H. pylori-mediated increases in NF-κB-p65 nuclear staining, transcriptional activity, and expression of proinflammatory cytokine genes (tumor necrosis factor α, interleukin 1β, chemokine [C-X-C motif] ligand 5, and interleukin 4 receptor) that were associated with reductions in the expression and phosphorylation of NF-κB-p65 and IκB kinase α/β proteins. The in vivo studies using the Tff1-KO mouse model of gastric neoplasia confirmed the in vitro findings. Furthermore, they demonstrated increases in chronic inflammation scores and in the frequency of invasive gastric adenocarcinoma in the Tff1-KO mice infected with H. pylori versus the uninfected Tff1-KO mice. CONCLUSIONS: These findings underscore an important protective role of TFF1 in abrogating H. pylori-mediated inflammation, a crucial hallmark of gastric tumorigenesis. Therefore, loss of TFF1 expression could be an important step in H. pylori-mediated gastric carcinogenesis.
Authors: W S Park; R R Oh; J Y Park; J H Lee; M S Shin; H S Kim; H K Lee; Y S Kim; S Y Kim; S H Lee; N J Yoo; J Y Lee Journal: Gastroenterology Date: 2000-09 Impact factor: 22.682
Authors: Mohammed Soutto; DunFa Peng; Ahmed Katsha; Zheng Chen; Maria Blanca Piazuelo; Mary Kay Washington; Abbes Belkhiri; Pelayo Correa; Wael El-Rifai Journal: Gut Date: 2014-08-08 Impact factor: 23.059
Authors: Marguerite Clyne; Paul Dillon; Stephen Daly; Richard O'Kennedy; Felicity E B May; Bruce R Westley; Brendan Drumm Journal: Proc Natl Acad Sci U S A Date: 2004-05-03 Impact factor: 11.205
Authors: R A Alm; L S Ling; D T Moir; B L King; E D Brown; P C Doig; D R Smith; B Noonan; B C Guild; B L deJonge; G Carmel; P J Tummino; A Caruso; M Uria-Nickelsen; D M Mills; C Ives; R Gibson; D Merberg; S D Mills; Q Jiang; D E Taylor; G F Vovis; T J Trust Journal: Nature Date: 1999-01-14 Impact factor: 49.962
Authors: Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray Journal: Int J Cancer Date: 2014-10-09 Impact factor: 7.396
Authors: Rafal S Sobota; Nuri Kodaman; Robertino Mera; M Blanca Piazuelo; Luis E Bravo; Alvaro Pazos; Jovanny Zabaleta; Alberto G Delgado; Wael El-Rifai; Douglas R Morgan; Keith T Wilson; Pelayo Correa; Scott M Williams; Barbara G Schneider Journal: Hum Genet Date: 2016-05-25 Impact factor: 4.132